Background The topology of the blood supply chain network can take different forms in different settings, depending on geography, politics, costs, etc. Many developed countries are moving towards centralized networks. The goal for all blood distribution networks, regardless of topology, remains the same: to satisfy demand at minimal cost and minimal wastage.
Introduction
The blood supply chain (BSC) can be subdivided into stages: collection, production, inventory and distribution [1] . Blood collection is an activity that requires enormous effort: donations are voluntary where the willingness of donors depends on factors such as distance they must travel, and their experienced level of physical discomfort, amongst others. Different methods can be used for collection, each of which impacts the number and type of finished products obtained and their costs. Most developed countries have, or are moving towards, centralized blood supply chains that rely on large regional production and distribution centres; the level of centralization is, typically, lower in developing countries.
Most blood products are obtained from whole blood. Each donor provides one unit of blood that is separated into different components (red blood cells (RBCs), plasma, platelets and cryoprecipitate using a second separation), yielding different quantities of output product, depending on the collection and separation strategy employed. By contrast, during apheresis collection, the donor is attached to a machine that extracts only the desired component. The equipment required for apheresis collection is considerably more expensive than that for whole blood donation. However, the yield per donor is much greater; for example, apheresis provides five to ten times as many platelets per donation, and thus, collection strategies can be much more targeted. Most studies in the modelling literature, however, only consider whole blood donation.
In the BSC, production decisions must consider demand for products, the availability of donations, product compatibility and collection and production alternatives. Given the vast range of collection and separation alternatives, geographical conditions and increasing cost, determining an optimal network configuration is a highly challenging problem. This solution must bound production factors, collection strategies and economic, political, geographical and even cultural considerations. Table 1 presents the most common collection processes.
The benefits of centralization in the blood supply chain are well documented in the literature [2, 3] . Economy of scale is a key driver of centralization. Building and maintaining blood supply chain infrastructure are expensive; hence, location decisions are typically regarded as strategic; many authors have studied location and allocation decisions in blood supply chains [4, 5, 6, 7] .
Decision-making in production planning in the blood supply chain has received comparatively little attention in the modelling literature. Analytical models have been developed to minimize production cost [8, 9] . Special attention has been paid to platelets because of their short shelf-life [10] [11] [12] , but few incorporate production planning into network design decisions.
Design of the blood supply chain has gained importance in recent years, with several publications focusing on building better blood networks under differing conditions, such as disasters [13] , uncertainty [14] and the requirement to meet social aspects [15] . The main approach used is optimization; however, simulation has also been used to support network design decisions [16] . Other recent publications study production planning [17] as well as the trade-off between whole blood and apheresis donations [18] . Several papers regarding strategic aspects of blood supply chain management have been recently published in the blood services literature. Examples include an evaluation of centralization using a real case in sub-Saharan Africa [19] , studies focusing on good inventory practices [20] or implementing optimal ordering and allocation policies [21] .
A key consideration for blood supply networks is the level of centralization. Centralization exploits economies of scale. When fixed cost can be allocated over a large number of units, economies of scale tend to favour large production centres; the cost of a blood unit processed in a large blood centre can be 40% lower than a unit processed in a small blood bank [22] where production volumes are typically lower; for example in Colombia, 48% of BSC facilities produce less than 5000 units annually [23] .
Despite the benefits of centralization, many examples of decentralized BSCs can be found. Most are in developing countries, like Brazil, where 530 blood banks collected 3Á3 million blood units in 2012 or Venezuela where 316 blood banks collected 445 000 blood units in the same year [24] . In developed countries, such as the United States, 79 blood centres are needed to serve a population of 330 million [25] . The reasons for retaining a decentralized design differ from country to country, though large distances, high transportation costs and geographic remoteness tend to favour decentralized systems. Transportation difficulties may simply dictate a requirement for local blood centres to avoid the risk of stockouts. Decentralized networks, furthermore, provide local economic development and generate employment opportunities within regions. Finally, in some jurisdictions, the presence of competing agencies may make centralization difficult to implement. Examples of a decentralized system (Colombia) and a centralized system (the UK) are given in Fig. 1 , with locations of blood production centres shown in yellow. Human resources also affect centralization decisions. Centralization requires specialized labour to handle large quantities of products. Decentralized systems, while less complex, may require trained staff in to exist in remote or rural areas; sufficient staff may be difficult to find in such locales. Nevertheless, decisions regarding the level of centralization tend to be dominated by geography, particularly with respect to the location of collection and production facilities. This paper presents an analytical model to find the optimal configuration of a generic blood supply chain. The model in this paper is unique; it includes multiple collection and separation methods and considers four major blood products (RBCs, plasma, platelets and cryoprecipitate), while setting location decisions simultaneously with capacity decisions. The approach supports decisions such as the optimal number and capacity of blood facilities, including collection, production and distribution centres, at varying levels of centralization. To illustrate the approach, a case study is presented using data derived from Colombia.
Materials and methods
To find the optimal configuration of the blood supply chain and an optimal collection and production strategy, we employ a technique called mathematical programming. A mathematical programming model consists of decision variables that represent the decisions to be made, and constraints that make the model logically consistent. The solution to the model provides optimal values for the decision variables that maximize or minimize one or more objective functions (targets). A typical objective function in the blood supply chain is the minimization of total cost. A schematic representation of our model is presented in Fig. 2 .
Decision variables
The decision variables in our model (shown in Fig. 2 ) relate to decisions in three of the four echelons of the blood supply chain. At the collection stage, we include decisions on the location and capacity of collection centres; this also includes the number of apheresis machines needed to meet RBC and platelet apheresis requirements. At the production stage, the decision variables define the location and capacity of blood production centres, as well as the number of units to be processed in each centre. Finally, in the inventory and storage stage, we consider the location and capacity of distribution centres. At this level, the allocation of demand zones to distribution centres is determined, but the distribution stage is not modelled in detail.
Objective function
In our model, the objective is to minimize costs over a 1-year period. The costs considered in our model are presented in Fig. 2 . This cost function comprises the fixed costs for the facilities, variable collection and production costs, variable handling costs, and inventory and transport costs, as well as penalties for stockouts. Fixed costs for facilities include a set-up cost associated with the physical facility and a stepcost based on the capacity chosen. For collection centres, capacity is measured in number of donors; at the production stage, capacity refers to the number of whole blood units that can be processed; and for distribution centres, capacity refers to individual products handled. The model is a proof-of-concept, and therefore, some broad assumptions are made, mainly due to a paucity of detailed data. Staffing costs (salaries) are included in this step-cost, but in practice, staffing costs are semi-variable costs. Variable costs include the collection cost per donor for each collection method, and the production cost per unit processed. At distribution centres, variable costs include both the cost of keeping inventory and the handling cost for units dispatched. Finally, we include the costs of transporting the required units of blood between different stages.
To apply the model to a specific case, appropriate cost data must be used. Since the aim of this paper was to present ab approach applicable to the design of any blood supply chain, the costs used in our case study example were all obtained from information in the public domain. The fixed cost data were obtained from PAHO [22] and adjusted where necessary. Transport costs were assumed to be a function of travel time ($0Á5/h) and were obtained using Google Maps. Variable costs were extracted from PAHO [22] ; inventory cost and handling cost were assumed to be a percentage of the value of the product.
Constraints
Decisions about the design supply of the blood supply chain must meet numerous practical and regulatory constraints. The model proposed in this paper contains the following assumptions; we recognize that many of these are oversimplifications, but the corresponding parameters could easily be modified in practice if more detailed data were available.
• Demand is defined in terms of population size in each geographical region and is not only variable but also unknown in advance. • Collection, production and distribution are limited to a predetermined capacity.
• Handling costs are a fixed percentage of the product cost.
• The total number of products obtained is adjusted by a historical discard rate, to take account of blood which fails quality tests.
• The maximum travel distances between the different stages are predefined by the decision-maker.
• Stockouts are highly undesirable and are heavily penalized in the model at $1000 US per unit. As this is a strategic-level model, stockouts are not 'real' stockouts that would occur in practice, but a proxy for lack of capacity to meet demand; $1000 is therefore not a real cost, but a modelling device to favour strongly those solutions in which demand is fully met.
• Apheresis collection processes can be carried out in whole blood collection centres only.
Solution method
The model described in Sections 3Á1 to 3Á3 can be solved exactly, using mathematical methods, and assuming fixed demand. However, in reality, demand is not fixed, and thus, any solutions obtained from such models may not be valid in practice. Our model therefore considers uncertainty in demand. The approach is based on a technique called sample average approximation (SAA) which simultaneously analyses multiple scenarios [26] generated by sampling from probability distributions. This approach has been widely used for industrial supply chain optimization. However, including multiple scenarios at the same time makes the model very difficult to solve, especially for large systems. For this reason, we propose a heuristic, or approximate, method based on the SAA approach that allows near-optimal solutions to be obtained in reasonable computation time. In general terms, the heuristic solves the model for individual scenarios and looks at "good" and "bad" locations, based on the number of times each location appears in the individual scenarios. These decisions are then fixed, and the model is solved again considering all scenarios simultaneously. A fuller, more technical explanation and the mathematical representation of our approach can be found in Osorio [27] .
Data and case study
The blood supply chain in Colombia consists of 82 blood banks and 414 transfusion providers, distributed across 32 regions and the capital, Bogota. The high level of decentralization means that indicators such as the outdating rate and cost are likely to be higher than for more centralized systems. In Colombia, the network comprises many different agencies, including both public and private blood centres.
Another feature of the Colombian system is the difference in collection strategies throughout the country. Each region defines its own collection goals for blood and blood products using local decision rules. For example, the highest proportion of platelets collected by apheresis in 2012 was in the Valle del Cauca region at 93%, followed by Antioquia at 42%. However, most regions obtain platelets from whole blood donations.
In our model, we consider 32 potential locations for collection and production centres, corresponding to the 32 regional capital cities, and 36 potential locations for distribution centres, based on the current location of blood banks. We grouped the 414 transfusion centres by city and considered 120 demand points. The data used are in the public domain (Instituto Nacional de Salud [28] ). The probability distributions for annual demand are assumed to be triangular, since there was not enough information available to apply statistical procedures to fit a more precise probability distribution.
We assume that exactly 4% of the population will donate blood, based on historical donation rates from this population. In practice, this percentage may differ between regions, but in the case study, we assume it is uniform throughout the country.
Scenarios studied
As mentioned in Section 1, our approach is flexible and thus allows several features such as uncertainty, and preferences to be modelled within the mathematical framework. We compare network configurations with different levels of centralization, by varying the maximum travel times allowed between the different stages.
Seven different scenarios are studied, as shown in Table 2 . The maximum times between collection and production reflect the regulations that apply in Colombia but could easily be adapted for other countries. In the scenarios, we consider the impact on the supply chain network configuration of assuming different maximum permitted travel times between stages. The travel time between production and distribution centres is constrained in Scenarios S1 and S2, but in Scenarios S3-S7, it is not limited (this is denoted by the letter M), and thus, the model will define the location and capacity of production centres based solely on cost. Scenarios S1 to S7 reflect increasing levels of centralization.
The model can also consider several other design features, independently or in any combination, for example:
• The optimal design of the network given a fixed budget;
• The optimal design of the network for decentralization constraints;
• Optimal collection, production and distribution strategies for a predefined network;
• The impact of increasing the percentage of donations for each, or all, of the collection centres.
In addition, we have included service levels based on inventories and lead times. We consider two types of inventories. Firstly, cyclic inventory is the inventory available to cover the normal operation of hospitals. We have also included safety stock to ensure enough products to cover variations in demand. In terms of lead times, we have modelled these via model constraints concerning delivery times between collection and production centres, production and distribution centres, as well as between distribution centres and demand zones.
Finally, we note that policies such as stock rotation and lateral transshipments are not included in the model. These are normally operational decisions made to avoid expired units, rather than strategic decisions related to capacity and location. Table 3 presents detailed results of the application of the model to the demand data for the case study. We choose Scenarios S1 and S7 to draw insights, since these represent the extremes of decentralization and centralization, respectively.
Results
In Scenario S7, with the longest travel times permitted, only 10 collection centres, five production centres and 13 distribution centres are needed, in contrast to 17, 15 and 22, respectively, for the most decentralized scenario, S1. The number of donors is lowest in Scenario S1, but this scenario results in the highest number of stockouts because several remote regions have very low populations and cannot supply enough blood without violating the distance constraints. It should be noted that the total capacity required, for production and elsewhere in the supply chain, is greater for Scenario S1 than for S7; however, since the number of donors is lower, capacity is used less efficiently in this scenario. Figure 3 compares the results of Scenarios S1 and S7 geographically. Yellow (lighter) icons show locations where both a production centre and a distribution centre are recommended. Red (darker) icons represent distribution centres only, and small green circles are demand points. Table 4 presents an optimal collection rate for each collection centre under Scenario S7. The aggregated, or national, collection strategy indicates that 37Á9% of the blood should be collected using triplex bags, with 61Á8% using quadruple bags, and the remaining 0Á3% of donors assigned to RBCs by apheresis. However, the collection strategy varies for the different collection centres. For example, the percentages for the blood collection centre located in Medell ın are 40% and 60% for triplex bags and quadruple bags, respectively; in Pereira, results are 64% and 36%, respectively.
As shown in Table 4 , the solution obtained for Scenario S7 recommends the acquisition of two RBC apheresis machines for the Cartagena and Cali collection centres. This occurs in Cartagena because of the constraint on the maximum percentage of donors in the region. In contrast, in Cali, the available number of donors could cover this constraint, but it would be necessary to expand the capacity by 10 000 units, which is more expensive than obtaining the same number of RBCs using apheresis. However, the number of donors allocated to this process is low in both locations, and thus, the decision-maker might consider whether simply increasing whole blood collection capacity in the region is more practical. Note that we have used a step capacity of 10 000 units in this example, but this value can be altered to suit local conditions. CCs, collection centres; PCs, production centres; DCs, distribution centres; DPs, demand points; M, no constraint.
In addition, results include the optimal separation strategy for each production centre. In Table 5 , the optimal separation strategy nationwide with Scenario S7 is shown to be 89% for alternative A quadruple bags (RBCs, plasma and platelets) and 11% for alternative B (RBCs and cryoprecipitate). These values are similar for all production centres. (a) Scenario S1 (b) Scenario S7 
Discussion
In this paper, we have presented a generic model for finding an optimal configuration of a blood supply chain network. The model can be applied in any setting and incorporates features that were not included in previous models in the literature.
In its most general form, the model assumes that it is possible to redesign the blood supply chain from scratch. Obviously, this is unrealistic in practice, but the model can be easily modified to incorporate existing facilities and constraints (e.g. regulatory, geographical or economic) in any real-world system.
One of the important aspects of the model is the a priori selection of a set of feasible locations for facilities, depending on the type of facility. For example, the location of collection centres should take account of aspects such as accessibility. Access to main roads is important for production centres, given the high frequency of inbound and outbound transport. The same applies to distribution centres, but here it is also necessary to consider demand for emergency orders. In terms of implementation of redesign projects in the blood supply chain, the evidence from Canada and the UK suggests that the centralization process takes place in stages. Thus, any reconfiguration of the network will usually be a gradual process.
Centralization of collection centres is less feasible than at the production stage, since it is unrealistic to expect donors to travel long distances. From a centralization point of view, the location of blood production centres is influenced by the travel time between collection centres and distribution centres. This means that in smaller countries with shorter travel times, centralization can be particularly attractive. Centralization in the collection stage also prevents duplication of services and eliminates competition for donors and customers between different agencies within a region.
The location of distribution centres depends on the required service level to demand points and thus is determined by the frequency and volume of periodical orders from hospitals as well as their location. In addition, centralization of distribution centres also reduces safety stock. From inventory theory, it is known that safety stock should be proportional to demand variability. If it is possible to operate fewer, larger distribution centres, with less variability, less safety stock is required. Centralization also decreases wastage, since inventories tend to flow more freely between supply and demand nodes. Centralized supply chains also require fewer physical assets.
In practice, the model is a decision-support tool and is, to some extent, a 'black box'. The model can inform decisions and provide impartial quantitative evidence, but model solutions must be carefully analysed and interpreted in context by human decisionmakers. The solutions returned are based on the information and constraints given to the model; however, in real life, constraints can sometimes be relaxed, and thus, several different solution scenarios could be envisioned.
Finally, the model presented here can be applied anywhere in the world, regardless of process design, number of actors involved or geography; the objective function, decision variables and constraints can be tailored for a wide range of systems including both centralized and decentralized blood systems. We therefore suggest that this framework represents an important development in models for blood system design and operations. 
